If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSND.L Regulatory News (SND)

  • There is currently no data for SND

Grant of EMI Share Options

21 Jul 2023 11:39

RNS Number : 8305G
Sondrel (Holdings) plc
21 July 2023
 

21 July 2023

Sondrel (Holdings) plc

("Sondrel", the "Company" and together with its subsidiaries the "Group")

 

Grant of EMI Share Options

 

Sondrel (Holdings) plc (AIM: SND), the fabless semiconductor business providing turnkey services in the design and delivery of 'application specific integrated circuits' (ASICs) and 'system on chips' (SoCs) for leading global technology brands, announces that it has granted options over 387,597 new ordinary shares in the Company under the Company's EMI Share Option Plan to Gareth Jones, Vice President ASIC and a PDMR of the Group (the "Options").

 

The terms of the Sondrel EMI Share Option Plan were announced by the Company on 1 June 2023 and approved by the Company's shareholders on 27 June 2023.

 

The Options will vest in tranches over a four-year period subject to customary malus and clawback provisions, with 50% of the Options granted vesting on the second anniversary of grant, a further 25% vesting on the third anniversary of grant and a final 25% vesting on the fourth anniversary of grant.

 

Vested Options will be capable of exercise in whole or in part at an exercise price of 56.5 pence per new ordinary share at any time prior to the tenth anniversary of grant.

 

Further detail is provided below in accordance with Article 19.3 of the Market Abuse Regulation.

 

Enquiries:

 

Sondrel (Holdings) plc

Via Buchanan

Graham Curren, CEO

Tel: +44 (0) 20 7466 5000

Joe Lopez, CFO

Cenkos Securities plc

Tel: +44 (0)20 7397 8900

Ben Jeynes / Katy Birkin / George Lawson - Corporate Finance

Alex Pollen / Michael Johnson - Sales

Buchanan Communications

Tel: +44 (0) 20 7466 5000

Chris Lane

Stephanie Whitmore

sondrel@buchanan.uk.com

 

Jack Devoy

Abby Gilchrist

About Sondrel

Sondrel is a UK-based fabless semiconductor company specialising in high end, complex digital Application Specific Integrated Circuits (ASICs) and System on Chips (SOCs). It provides a full turnkey service in the design, prototyping, testing, packaging and production of ASICs and SoCs.

 

The Company is one of only a few companies capable of designing and supplying the higher-spec chips built on the most advanced semiconductor technologies, selling into a range of hyper growth end markets such as high-performance computing, automotive, artificial intelligence, VR/AR, video analytics, image processing, mobile networking and data centres. Sondrel designs have enabled products by leading technology brands including Apple (iPhone), Sony (PlayStation), Meta's (Oculus), Samsung, Google and Sony smartphones, JVC (prosumer camcorders), Tesla and Mercedes-Benz cars.

 

Sondrel is well-established, with a 20-year track record of successful delivery, supported by long standing ecosystem partnerships including Arm, TSMC and Samsung. Headquartered in the UK, Sondrel has a global presence with offices in UK, USA, China, India and Morocco.

 

For more information please visit: www.ir.sondrel.com.

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Gareth Jones

 

2

 

Reason for the notification

a)

 

Position/status

PDMR (Vice President ASIC)

 

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sondrel (Holdings) plc

b)

 

LEI

 

984500D6E7L2A9A54935

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of £0.001 each

 

 

ISIN: GB00BJN54579

 

b)

 

Nature of the transaction

 

Grants of options under the Sondrel EMI Share Option Plan

 

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Nil

 

387,597

 

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

n/a

 

 

n/a

 

e)

 

Date of the transaction

 

21 July 2023

f)

 

Place of the transaction

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVIDDILFIV
Date   Source Headline
21st Aug 20247:00 amRNSCancellation - Sondrel (Holdings) plc
12th Aug 20241:54 pmRNSResult of GM, Cancellation and Re-registration
22nd Jul 20247:00 amRNSProposed cancellation of Admission, Notice of GM
18th Jul 20248:09 amRNSFinal Results and Posting of Annual Report-Replace
18th Jul 20247:30 amRNSRestoration - Sondrel (Holdings) plc
18th Jul 20247:01 amRNSChief Financial Officer Succession
18th Jul 20247:00 amRNSFinal Results and Posting of Annual Report
16th Jul 20247:00 amRNSNotice of Results
1st Jul 20247:30 amRNSSuspension - Sondrel (Holdings) plc
27th Jun 20245:32 pmRNSResult of AGM
24th Jun 20244:26 pmRNSSuspension of Trading on AIM
18th Jun 20247:00 amRNSDirectorate Changes
12th Jun 202412:45 pmRNSUpdate re Subscription and Loan Conversion
10th Jun 202410:40 amRNSReceipt of NSIA Approval
30th May 20241:52 pmRNSResult of General Meeting
29th May 20246:07 pmRNSNotice of AGM
29th May 20247:00 amRNSRegulatory Condition to Conditional Subscription
22nd May 20247:00 amRNSChief Executive Officer Succession
14th May 20247:00 amRNSSubscription and Posting of Circular
29th Apr 20242:35 pmRNSPDMR Dealing
29th Apr 20247:00 amRNSSuccessful Milestone Completion
22nd Apr 20244:45 pmRNSPDMR Dealings
10th Apr 20245:26 pmRNSNotification of Major Holdings
2nd Apr 20249:39 amRNSNotification of Major Holdings
28th Mar 20241:08 pmRNSFurther CLN and Amended Exclusivity Agreement
27th Mar 20244:55 pmRNSUpdated Supply Arrangements
25th Mar 20243:46 pmRNSResult of General Meeting
25th Mar 20247:00 amRNSFurther re Material ASIC contract
11th Mar 20247:00 amRNSPosting of Circular and Notice of General Meeting
6th Mar 20247:00 amRNSConvertible Loan Note and Exclusivity Agreement
1st Mar 20247:00 amRNSFurther re Corporate Update
27th Feb 202412:52 pmRNSReplacement: Notification of Major Holdings
27th Feb 20248:33 amRNSNotification of Major Holdings
27th Feb 20247:00 amRNSNew Contract Win and Corporate Update
8th Feb 20248:42 amRNSStatement re Share Price Movement
5th Feb 20247:00 amRNSCorporate Update
10th Jan 20247:00 amRNSFY23 Update
5th Jan 20247:00 amRNSBoard Change
28th Dec 20232:52 pmRNSTrading Update
1st Dec 20233:31 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSResult of placing of shares in Sondrel (Holdings)
23rd Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Nov 20237:00 amRNSProduction Order
20th Oct 20237:00 amRNSFounding member of Arm Total Design ecosystem
27th Sep 202312:01 pmRNSNotification of Major Holdings
27th Sep 202311:57 amRNSNotification of Major Holdings
21st Sep 20237:00 amRNSDelivery of prototypes for three ASIC projects
21st Sep 20237:00 amRNSResults for the half year ended 30 June 2023
20th Sep 20231:09 pmRNSBoard Update
18th Sep 20237:00 amRNSSenior Management Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.